Advances in Spatial Genomics
Castle Biosciences Acquires Cernostics for up to $80M
Cernostics specializes in spatial biology and artificial intelligence-driven image analysis of tissue biopsies.
NanoString Technologies, OHSU Partner on Breast Cancer Spatial Protein Profiling Assay Development
A new GeoMx Digital Spatial Profiler assay will have up to 30 protein targets and will be validated for potential use as a laboratory-developed test.
HTG to Expand Disease Reach With New Whole-Transcriptome Profiling Product Mid-2021
The firm aims to launch an early-access program by the end of the year, followed by a second white paper before the JP Morgan Healthcare Conference in January.Â
BioSkryb, St. Jude Expand Licensing Deal for Dx Applications of Single-Cell Tech
BioSkryb will now have an exclusive global license for clinical applications of primary template directed amplification technology.
SkylineDx, BioInvent Collaborate to Characterize Predictive Immunological Signatures for Cancers
SkylineDx said that the firms will work together to develop predictive immunological signatures for BioInvent's lead therapy candidate.